EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| ChEBI ID | CHEBI:754227 |
| ChEBI Name | otilimab |
| Stars | |
| Last Modified | 29 June 2026 |
| Submitter | ChEMBL |
| Roles Classification |
|---|
| Biological Roles: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antiviral agent A substance that destroys or inhibits replication of viruses. |
| Applications: | immunosuppressive agent An agent that suppresses immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-cells or by inhibiting the activation of helper cells. In addition, an immunosuppressive agent is a role played by a compound which is exhibited by a capability to diminish the extent and/or voracity of an immune response. antirheumatic drug A drug used to treat rheumatoid arthritis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| otilimab (CHEBI:754227) has role antirheumatic drug (CHEBI:35842) |
| otilimab (CHEBI:754227) has role antiviral agent (CHEBI:22587) |
| otilimab (CHEBI:754227) has role immunosuppressive agent (CHEBI:35705) |
| otilimab (CHEBI:754227) is a organic molecular entity (CHEBI:50860) |
| INN | Source |
|---|---|
| otilimab | WHO MedNet |
| Synonyms | Source |
|---|---|
| GSK-3196165 | ChEMBL |
| GSK3196165 | ChEMBL |
| MOR-103 | ChEMBL |
| MOR103 | ChEMBL |